JNGLX
Price
$73.84
Change
-$1.03 (-1.38%)
Updated
Oct 10 closing price
Net Assets
4.57B
LHCSX
Price
$20.55
Change
-$0.27 (-1.30%)
Updated
Oct 10 closing price
Net Assets
8.11M
Interact to see
Advertisement

JNGLX vs LHCSX

Header iconJNGLX vs LHCSX Comparison
Open Charts JNGLX vs LHCSXBanner chart's image
Janus Henderson Global Life Sciences D
Price$73.84
Change-$1.03 (-1.38%)
VolumeN/A
Net Assets4.57B
Lord Abbett Health Care R4
Price$20.55
Change-$0.27 (-1.30%)
VolumeN/A
Net Assets8.11M
JNGLX vs LHCSX Comparison Chart in %
View a ticker or compare two or three
VS
JNGLX vs. LHCSX commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and LHCSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.57B vs. LHCSX (8.11M). JNGLX pays higher dividends than LHCSX: JNGLX (0.33) vs LHCSX (0.31). JNGLX was incepted earlier than LHCSX: JNGLX (27 years) vs LHCSX (6 years). LHCSX (3.34) is less costly to investors than JNGLX (0.80). LHCSX is a more actively managed with annual turnover of: 88.00 vs. JNGLX (35.00). LHCSX has a lower initial minimum investment than JNGLX: LHCSX (0) vs JNGLX (2500). LHCSX annual gain was more profitable for investors over the last year : 5.26 vs. JNGLX (-5.69). JNGLX return over 5 years is better than : 8.98 vs. LHCSX (1.47).
JNGLXLHCSXJNGLX / LHCSX
Total Expense Ratio0.801.0378%
Annual Report Gross Expense Ratio0.803.3424%
Fund Existence27 years6 years-
Gain YTD10.2818.721118%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.57B8.11M56,380%
Annual Yield % from dividends0.330.31107%
Returns for 1 year-5.695.26-108%
Returns for 3 years26.1530.2886%
Returns for 5 years8.981.47610%
Returns for 10 years45.22N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVINX40.95N/A
N/A
Macquarie Global Growth Fund Class A
MCVIX33.13N/A
N/A
MFS Mid Cap Value I
STFBX97.48N/A
N/A
State Farm Balanced
HISFX16.05N/A
N/A
Hennessy Small Cap Financial Instl
BRSDX15.19N/A
N/A
MFS Blended Research Small Cap Eq A